Literature DB >> 10407043

Increased anxiety and impaired pain response in puromycin-sensitive aminopeptidase gene-deficient mice obtained by a mouse gene-trap method.

T Osada1, S Ikegami, K Takiguchi-Hayashi, Y Yamazaki, Y Katoh-Fukui, T Higashinakagawa, Y Sakaki, T Takeuchi.   

Abstract

A mouse mutation, termed goku, was generated by a gene-trap strategy. goku homozygous mice showed dwarfism, a marked increase in anxiety, and an analgesic effect. Molecular analysis indicated that the mutated gene encodes a puromycin-sensitive aminopeptidase (Psa; EC 3. 4.11.14), whose functions in vivo are unknown. Transcriptional arrest of the Psa gene and a drastic decrease of aminopeptidase activity indicated that the function of Psa is disrupted in homozygous mice. Together with the finding that the Psa gene is strongly expressed in the brain, especially in the striatum and hippocampus, these results suggest that the Psa gene is required for normal growth and the behavior associated with anxiety and pain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407043      PMCID: PMC6783060     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

Review 1.  Null mutations lacking substance: elucidating pain mechanisms by genetic pharmacology.

Authors:  C J Woolf; R J Mannion; S Neumann
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

2.  Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?

Authors:  R Gerlai
Journal:  Trends Neurosci       Date:  1996-05       Impact factor: 13.837

Review 3.  Mouse gene trap approach: identification of novel genes and characterization of their biological functions.

Authors:  K Kitajima; T Takeuchi
Journal:  Biochem Cell Biol       Date:  1998       Impact factor: 3.626

4.  The use of a plus-maze to measure anxiety in the mouse.

Authors:  R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Endogenous opiates: 1995.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1996       Impact factor: 3.750

6.  Latexin expression in smaller diameter primary sensory neurons in the rat.

Authors:  K Takiguchi-Hayashi; M Sato; N Sugo; M Ishida; K Sato; Y Uratani; Y Arimatsu
Journal:  Brain Res       Date:  1998-08-10       Impact factor: 3.252

7.  Pain measurement: an overview.

Authors:  C R Chapman; K L Casey; R Dubner; K M Foley; R H Gracely; A E Reading
Journal:  Pain       Date:  1985-05       Impact factor: 6.961

8.  Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6.

Authors:  E M Eicher; W G Beamer
Journal:  J Hered       Date:  1976 Mar-Apr       Impact factor: 2.645

9.  New mouse dw allele: genetic location and effects on lifespan and growth hormone levels.

Authors:  E M Eicher; W G Beamer
Journal:  J Hered       Date:  1980 May-Jun       Impact factor: 2.645

10.  Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

Authors:  S Pellow; S E File
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

View more
  16 in total

1.  A new type of neuron-specific aminopeptidase NAP-2 in rat brain synaptosomes.

Authors:  Maria Hui; Koon-Sea Hui
Journal:  Neurochem Int       Date:  2008-09-11       Impact factor: 3.921

Review 2.  Census of cytosolic aminopeptidase activity reveals two novel cytosolic aminopeptidases.

Authors:  Nadja Akkad; Mark Schatz; Jörn Dengjel; Stefan Tenzer; Hansjörg Schild
Journal:  Med Microbiol Immunol       Date:  2012-09-14       Impact factor: 3.402

3.  Opioid-Induced Hyperalgesia Is Associated with Dysregulation of Circadian Rhythm and Adaptive Immune Pathways in the Mouse Trigeminal Ganglia and Nucleus Accumbens.

Authors:  Pan Zhang; Laura S Moye; Bruce R Southey; Isaac Dripps; Jonathan V Sweedler; Amynah Pradhan; Sandra L Rodriguez-Zas
Journal:  Mol Neurobiol       Date:  2019-05-25       Impact factor: 5.590

4.  Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.

Authors:  Katherine A Jackman; Vanessa H Brait; Yutang Wang; Ghassan J Maghzal; Helen J Ball; Gavin McKenzie; T Michael De Silva; Roland Stocker; Christopher G Sobey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-27       Impact factor: 3.000

5.  Functional gene expression analysis of tissue-specific isoforms of Mef2c.

Authors:  Yoshiharu Sekiyama; Hitoshi Suzuki; Toshifumi Tsukahara
Journal:  Cell Mol Neurobiol       Date:  2011-08-14       Impact factor: 5.046

6.  Neuron-specific aminopeptidase and puromycin-sensitive aminopeptidase in rat brain development.

Authors:  Maria Hui; Koon-Sea Hui
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

Review 7.  Brain-specific aminopeptidase: from enkephalinase to protector against neurodegeneration.

Authors:  Koon-Sea Hui
Journal:  Neurochem Res       Date:  2007-05-03       Impact factor: 3.996

8.  Puromycin-sensitive aminopeptidase: an antiviral prodrug activating enzyme.

Authors:  Ulrika Tehler; Cara H Nelson; Larryn W Peterson; Chester J Provoda; John M Hilfinger; Kyung-Dall Lee; Charles E McKenna; Gordon L Amidon
Journal:  Antiviral Res       Date:  2009-12-05       Impact factor: 5.970

9.  Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy.

Authors:  Fiona M Menzies; Raphael Hourez; Sara Imarisio; Marcel Raspe; Oana Sadiq; Dhia Chandraratna; Cahir O'Kane; Kenneth L Rock; Eric Reits; Alfred L Goldberg; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-09-09       Impact factor: 6.150

Review 10.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.